Canada Goose Holdings Inc. (GOOS)

Achilles Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 29, 2025	Mar 30, 2025	Mar 31, 2024	Apr 2, 2023	Apr 3, 2022	Mar 28, 2021
Cash & Equivalents	180.5	334.4	144.9	286.5	287.7	477.9
Cash & Short-Term Investments	180.5	334.4	144.9	286.5	287.7	477.9
Cash Growth	191.60%	130.78%	-49.42%	-0.42%	-39.80%	1407.57%
Accounts Receivable	73.1	82.8	70.4	50.9	42.7	40.9
Other Receivables	31.6	10.2	28	0.9	1.1	4.8
Receivables	104.7	93	98.4	51.8	43.8	45.7
Inventory	439.5	384	445.2	472.6	393.3	342.3
Other Current Assets	59	63.8	52.3	52.3	37.5	31
Total Current Assets	783.7	875.2	740.8	863.2	762.3	896.9
Property, Plant & Equipment	428.1	441.8	451.6	447.8	329.4	350.2
Goodwill	72	72	70.8	63.9	53.1	53.1
Other Intangible Assets	130.9	131.9	135.1	135.1	122.2	124.8
Long-Term Deferred Tax Assets	114.6	95.7	76.3	67.5	53.2	48.4
Other Long-Term Assets	1.2	0.1	7	12.5	20.4	5.1
Total Assets	1,531	1,617	1,482	1,590	1,341	1,479
Accounts Payable	64.7	39.6	57.6	60.1	63.9	78.9
Accrued Expenses	157.4	118.4	112.1	104.3	93.5	78.2
Short-Term Debt	12.6	-	5.4	23.5	-	-
Current Portion of Long-Term Debt	-	4.3	4	4.1	3.8	-
Current Portion of Leases	84.2	83.9	79.9	76.1	58.5	45.2
Current Income Taxes Payable	19.2	28.6	16.8	31.5	24.5	19.1
Other Current Liabilities	50.5	53.6	57.1	52.8	37.3	40.7
Total Current Liabilities	388.6	328.4	332.9	352.4	281.5	262.1
Long-Term Debt	388.6	407.7	388.5	391.6	366.2	367.8
Long-Term Leases	236.5	246.9	250.6	258.7	192.2	209.6
Long-Term Deferred Tax Liabilities	11.8	20.8	17.2	16.4	15.8	15.4
Other Long-Term Liabilities	58.4	56.3	68.9	93.4	57	46
Total Liabilities	1,084	1,060	1,058	1,113	912.7	900.9
Common Stock	113.3	109.6	104.9	118.7	118.5	120.5
Additional Paid-In Capital	65.7	65.4	54.4	28.5	36.2	25.2
Retained Earnings	221.5	346.7	252.5	316.5	290.4	437.1
Comprehensive Income & Other	31.2	19.5	5.2	5.8	-17.2	-5.2
Total Common Equity	431.7	541.2	417	469.5	427.9	577.6
Minority Interest	14.9	15.4	6.5	8	-	-
Shareholders' Equity	446.6	556.6	423.5	477.5	427.9	577.6
Total Liabilities & Equity	1,531	1,617	1,482	1,590	1,341	1,479
Total Debt	721.9	742.8	728.4	754	620.7	622.6
Net Cash (Debt)	-541.4	-408.4	-583.5	-467.5	-333	-144.7
Net Cash Per Share	-5.52	-4.16	-5.73	-4.43	-3.05	-1.30
Filing Date Shares Outstanding	97.07	96.83	96.55	103.94	105.19	110.44
Total Common Shares Outstanding	97.07	96.83	96.53	104.19	105.19	110.44
Working Capital	395.1	546.8	407.9	510.8	480.8	634.8
Book Value Per Share	4.45	5.59	4.32	4.51	4.07	5.23
Tangible Book Value	228.8	337.3	211.1	270.5	252.6	399.7
Tangible Book Value Per Share	2.36	3.48	2.19	2.60	2.40	3.62
Machinery	-	115.5	108.3	87.1	78.5	70.6
Construction In Progress	-	11.9	4.1	46.5	4.1	3.3
Leasehold Improvements	-	246.9	225.2	151.4	125.1	102.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q